KRISTAMEDA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,145,438 | 1,307,202 | 1,224,711 | 1,404,148 | 1,823,915 | 1,897,475 | 2,029,489 | 2,064,260 |
| Profit before tax | 278,658 | 438,054 | 458,961 | 524,398 | 607,827 | 726,290 | 834,904 | 940,702 |
| Net profit | 242,846 | 386,673 | 403,483 | 460,038 | 531,032 | 642,654 | 718,168 | 813,747 |
| Equity | 764,340 | 749,480 | 765,928 | 919,492 | 1,199,936 | 1,427,296 | 1,598,405 | 2,173,748 |
| Liabilities | 548,993 | 501,337 | 357,537 | 301,155 | 223,873 | 83,841 | 42,139 | 100,291 |
| Non-current assets | 980,181 | 925,668 | 862,870 | 798,051 | 866,255 | 869,474 | 910,463 | 1,745,492 |
| Current assets | 332,883 | 322,880 | 260,072 | 422,596 | 557,554 | 641,663 | 729,815 | 527,865 |
| Total assets | 1,313,064 | 1,248,548 | 1,122,942 | 1,220,647 | 1,423,809 | 1,511,137 | 1,640,278 | 2,273,357 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 253,136 | 303,732 | 299,522 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +8.0% | +14.1% | -6.3% | +14.7% | +29.9% | +4.0% | +7.0% | +1.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 18.5% | 31.0% | 35.9% | 37.7% | 37.3% | 42.5% | 43.8% | 35.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 31.8% | 51.6% | 52.7% | 50.0% | 44.3% | 45.0% | 44.9% | 37.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 21.2% | 29.6% | 32.9% | 32.8% | 29.1% | 33.9% | 35.4% | 39.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 24.3% | 33.5% | 37.5% | 37.3% | 33.3% | 38.3% | 41.1% | 45.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.7 | 0.7 | 0.5 | 0.3 | 0.2 | 0.1 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 381,813 | 435,734 | 408,237 | 468,049 | 607,972 | 632,492 | 676,496 | 688,087 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
KRISTAMEDA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-12-17 | 2024-12-20 | 139.73 |
KRISTAMEDA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
KRISTAMEDA, UAB (code 301245735) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €2.06M and net profit of €813.7K, resulting in a profit margin of 39.4%. Revenue increased by 1.7% year on year and by 8.8% over two years, showing gradual top-line growth. Profitability strengthened over the same period: net profit rose from €642.7K in 2023 to €718.2K in 2024 and €813.7K in 2025. The balance sheet remained strong, with total assets of €2.27M, equity of €2.17M and liabilities of €100.3K at year-end 2025. Key ratios point to a highly equity-financed structure, including an equity ratio of 95.6% and debt-to-equity of 0.05. ROE was 37.4% and ROA 35.8%, while asset turnover was 0.91x. Revenue per employee reached €688.1K and profit per employee €271.2K.